SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001626199-19-000040
Filing Date
2019-05-09
Accepted
2019-05-09 16:36:46
Documents
59
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a10q_2019q1.htm 10-Q 1211695
2 EXHIBIT 10.6 alpn-ex106_20190331.htm EX-10.6 368225
3 EXHIBIT 31.1 alpn-ex311_20190331.htm EX-31.1 11826
4 EXHIBIT 31.2 alpn-ex312_20190331.htm EX-31.2 11745
5 EXHIBIT 32.1 alpn-ex321_20190331.htm EX-32.1 6576
6 EXHIBIT 32.2 alpn-ex322_20190331.htm EX-32.2 6649
13 alpnex106_20190331-image.gif GRAPHIC 65083
  Complete submission text file 0001626199-19-000040.txt   4318308

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT alpn-20190331.xml EX-101.INS 532856
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20190331.xsd EX-101.SCH 32291
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alpn-20190331_cal.xml EX-101.CAL 57021
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alpn-20190331_def.xml EX-101.DEF 115162
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20190331_lab.xml EX-101.LAB 400288
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20190331_pre.xml EX-101.PRE 224695
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37449 | Film No.: 19811175
SIC: 2834 Pharmaceutical Preparations